0000899243-23-005241.txt : 20230216 0000899243-23-005241.hdr.sgml : 20230216 20230216160515 ACCESSION NUMBER: 0000899243-23-005241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Izumi Raquel E. CENTRAL INDEX KEY: 0001832553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39244 FILM NUMBER: 23638527 MAIL ADDRESS: STREET 1: 4500 GREAT AMERICA PKWY STREET 2: STE. 100 #29 CITY: SANTA CLARA STATE: CA ZIP: 95054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vincerx Pharma, Inc. CENTRAL INDEX KEY: 0001796129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833197402 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-800-6676 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Vincera Pharma, Inc. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: LifeSci Acquisition Corp. DATE OF NAME CHANGE: 20191206 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001796129 Vincerx Pharma, Inc. VINC 0001832553 Izumi Raquel E. 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306 1 1 0 0 See Remarks Stock Option (right to buy) 1.17 2023-02-15 4 A 0 90000 0.00 A 2033-02-14 Common Stock 90000 90000 D Option vests in twenty-four equal monthly installments starting from February 15, 2023. President and Chief Operations Officer Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022. By: /s/ Raquel E. Izumi 2023-02-16